Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 3
1987 2
1988 4
1989 2
1990 6
1991 10
1992 11
1993 2
1994 3
1995 2
1996 5
1997 13
1998 5
1999 9
2000 3
2002 1
2003 6
2004 8
2005 7
2006 12
2007 8
2008 10
2009 11
2010 5
2011 9
2012 15
2013 11
2014 8
2015 17
2016 13
2017 9
2018 13
2019 10
2020 4
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

247 results
Results by year
Filters applied: . Clear all
Page 1
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial.
Yamada Y, Denda T, Gamoh M, Iwanaga I, Yuki S, Shimodaira H, Nakamura M, Yamaguchi T, Ohori H, Kobayashi K, Tsuda M, Kobayashi Y, Miyamoto Y, Kotake M, Shimada K, Sato A, Morita S, Takahashi S, Komatsu Y, Ishioka C. Yamada Y, et al. Among authors: ishioka c. Ann Oncol. 2018 Mar 1;29(3):624-631. doi: 10.1093/annonc/mdx816. Ann Oncol. 2018. PMID: 29293874 Free PMC article. Clinical Trial.
247 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page